Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab

OBJECTIVE: Identify serum biomarkers modulated by golimumab treatment and associated with clinical response in patients with ankylosing spondylitis (AS). METHODS: Sera were collected at weeks 0, 4 and 14 from 100 patients with active AS in the GO–RAISE study. Patients were randomly assigned subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Carrie, Visvanathan, Sudha, Braun, Jürgen, van der Heijde, Désirée, Deodhar, Atul, Hsu, Benjamin, Mack, Michael, Elashoff, Michael, Inman, Robert D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329231/
https://www.ncbi.nlm.nih.gov/pubmed/22039165
http://dx.doi.org/10.1136/ard.2010.148890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329231/
https://www.ncbi.nlm.nih.gov/pubmed/22039165
http://dx.doi.org/10.1136/ard.2010.148890

Ejemplares similares